Joint Corp. (JYNT)
11.35
-0.10 (-0.87%)
At close: Feb 20, 2025, 3:59 PM
11.36
0.13%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 11 |
| Market Cap | 169.99M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.14 |
| PE Ratio (ttm) | -9.95 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 11.85 |
| Volume | 27,596 |
| Avg. Volume (20D) | 39,066 |
| Open | 11.38 |
| Previous Close | 11.45 |
| Day's Range | 11.29 - 11.43 |
| 52-Week Range | 9.10 - 17.82 |
| Beta | undefined |
About JYNT
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona....
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Nov 11, 2014
Employees 444
Stock Exchange NASDAQ
Ticker Symbol JYNT
Website https://www.thejoint.com
Analyst Forecast
According to 2 analyst ratings, the average rating for JYNT stock is "Buy." The 12-month stock price forecast is $17.5, which is an increase of 54.25% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Joint Corp. is scheduled to release its earnings on Mar 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+7.21%
The Joint Corp shares are trading higher after the...
Unlock content with
Pro Subscription
9 months ago
+25.35%
Joint shares are trading higher after the company reported better-than-expected Q1 financial results and reiterated FY23 system-wide sales guidance. Also, Roth MKM reiterated a Buy rating on the stock and raised its price target from $13 to $16.
